Company News 

Partnerships drive revenue higher at Oxford Biodynamics

Partnerships drive revenue higher at Oxford Biodynamics

American patent approval has given Oxford Biodynamics (OBD) scope for major expansion in the US – the world’s biggest healthcare market. During the half-year the group signed two collaborations with major US pharmaceutical companies in the fields of fibrosis and immuno-oncology – two fast-growing areas of medicine.

To continue reading, subscribe today

and enjoy unlimited access to the following:

  • Tips of the Week
  • Funds coverage
  • Weekly features on big investment themes
  • Trading ideas
  • Comprehensive companies coverage
  • Economic analysis
Subscribe
Subscribe to Investors Chronicle

Subscribe today

Full access for just £3.37 a week:

• Tips and recommendations - to beat the market 
• Portfolio clinic & Mr Bearbull - build a well-planned portfolio 
• Expert tools - track and manage investments effortlessly
• Plus free delivery to your home or office

Subscribe Now